Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide

D Bengtsson; H D Schrøder; K Berinder; D Maiter; C Hoybye; O Ragnarsson; U Feldt-Rasmussen; Å Krogh Rasmussen; A van der Lely; M Petersson; G Johannsson; M Andersen; P Burman

doi:10.1007/s12020-018-1751-9

Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide

D Bengtsson, H D Schrøder, K Berinder, D Maiter, C Hoybye, O Ragnarsson, U Feldt-Rasmussen, Å Krogh Rasmussen, A van der Lely, M Petersson, G Johannsson, M Andersen, P Burman

20 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Endocrine
Vol/bind	62
Udgave nummer	3
Sider (fra-til)	737-739
Antal sider	3
ISSN	1355-008X
DOI	https://doi.org/10.1007/s12020-018-1751-9
Status	Udgivet - dec. 2018

Adgang til dokumentet

10.1007/s12020-018-1751-9

Citationsformater

Bengtsson, D., Schrøder, H. D., Berinder, K., Maiter, D., Hoybye, C., Ragnarsson, O., Feldt-Rasmussen, U., Krogh Rasmussen, Å., van der Lely, A., Petersson, M., Johannsson, G., Andersen, M., & Burman, P. (2018). Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide. Endocrine, 62(3), 737-739. https://doi.org/10.1007/s12020-018-1751-9

Bengtsson, D, Schrøder, HD, Berinder, K, Maiter, D, Hoybye, C, Ragnarsson, O, Feldt-Rasmussen, U , Krogh Rasmussen, Å, van der Lely, A, Petersson, M, Johannsson, G, Andersen, M & Burman, P 2018, 'Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide', Endocrine, bind 62, nr. 3, s. 737-739. https://doi.org/10.1007/s12020-018-1751-9

@article{d430f2fbb0d94c088088207009740590,

title = "Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide",

author = "D Bengtsson and Schr{\o}der, {H D} and K Berinder and D Maiter and C Hoybye and O Ragnarsson and U Feldt-Rasmussen and {Krogh Rasmussen}, {\AA} and {van der Lely}, A and M Petersson and G Johannsson and M Andersen and P Burman",

year = "2018",

month = dec,

doi = "10.1007/s12020-018-1751-9",

language = "English",

volume = "62",

pages = "737--739",

journal = "Endocrine",

issn = "1355-008X",

publisher = "Springer",

number = "3",

}

TY - JOUR

T1 - Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide

AU - Bengtsson, D

AU - Schrøder, H D

AU - Berinder, K

AU - Maiter, D

AU - Hoybye, C

AU - Ragnarsson, O

AU - Feldt-Rasmussen, U

AU - Krogh Rasmussen, Å

AU - van der Lely, A

AU - Petersson, M

AU - Johannsson, G

AU - Andersen, M

AU - Burman, P

PY - 2018/12

Y1 - 2018/12

U2 - 10.1007/s12020-018-1751-9

DO - 10.1007/s12020-018-1751-9

M3 - Journal article

C2 - 30246233

SN - 1355-008X

VL - 62

SP - 737

EP - 739

JO - Endocrine

JF - Endocrine

IS - 3

ER -